Filing Details
- Accession Number:
- 0001225208-17-005738
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-03-07 16:21:38
- Reporting Period:
- 2017-03-03
- Filing Date:
- 2017-03-07
- Accepted Time:
- 2017-03-07 16:21:38
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
200406 | Johnson & Johnson | JNJ | Pharmaceutical Preparations (2834) | 221024240 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1673401 | Joaquin Duato | One Johnson &Amp; Johnson Plaza New Brunswick NJ 08933 | Exec Vp, Ww Chair, Pharma | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-03-03 | 29,158 | $58.33 | 97,694 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2017-03-03 | 20,842 | $61.75 | 118,536 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-03-03 | 50,000 | $123.62 | 68,536 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Options (Right to Buy) | Disposition | 2017-03-03 | 29,158 | $0.00 | 29,158 | $58.33 |
Common Stock | Employee Stock Options (Right to Buy) | Disposition | 2017-03-03 | 20,842 | $0.00 | 20,842 | $61.75 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
5,130 | 2012-02-10 | 2019-02-08 | No | 4 | M | Direct |
0 | 2011-02-12 | 2018-02-10 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 570 | Indirect | By 401k |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $123.35 to $123.67. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (2/28/2017).